Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International multisite implementation of distributed cell-free protein biomanufacturing to advance health and research equity.

Science advances·2026
Same author

Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Chemotherapy and the somatic mutation burden of sperm.

JCI insight·2025
Same author

Retraction Note: Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Molecular cancer·2025
Same author

Derivation of a comprehensive semi-empirical proton RBE model from published experimental cell survival data collected in the PIDE database.

Frontiers in oncology·2024
Same author

Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.

American journal of otolaryngology·2023
Same journal

Comment on "Malignant transformation of verrucous oral potentially malignant disorders at a tertiary referral centre: A retrospective cohort study".

Oral oncology·2026
Same journal

Aquaporin-1 gene therapy as a novel method to treat radiation-induced salivary gland damage: The case for adeno-associated virus vectors.

Oral oncology·2026
Same journal

Patient preferences for mental health care in head and neck cancer: A head and neck cancer Alliance survey.

Oral oncology·2026
Same journal

3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects.

Oral oncology·2026
Same journal

Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland.

Oral oncology·2026
Same journal

A salivary protein panel for detecting malignant transformation of oral leukoplakia.

Oral oncology·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.9K

cfDNA detection for HPV+ squamous cell carcinomas.

Kate Chatfield-Reed1, Veronique P Roche2, Quintin Pan3

  • 1University Hospitals Seidman Cancer Center, Cleveland, OH 44106, United States; Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, United States.

Oral Oncology
|February 14, 2021
PubMed
Summary
This summary is machine-generated.

Detecting cell-free human papillomavirus (HPV) DNA in blood offers a promising liquid biopsy approach. This method can identify cancer progression and treatment relapse in HPV-associated cancers.

Keywords:
BiomarkerEarly detectionHPVLiquid biopsyddPCR

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.8K
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
08:08

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

16.1K

Related Experiment Videos

Last Updated: Nov 17, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.9K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.8K
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
08:08

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

16.1K

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Virology

Background:

  • High-risk human papillomavirus (HPV) is a key cause of anal, cervical, and oropharyngeal squamous cell carcinomas.
  • HPV cell-free DNA (cfDNA) circulates in the blood and can be detected via PCR or next-generation sequencing.
  • Elevated HPV cfDNA levels correlate with advanced cancer stages and metastasis.

Purpose of the Study:

  • To explore the clinical utility of HPV cfDNA as a liquid biopsy marker.
  • To assess the association of HPV cfDNA with prognostic variables and treatment outcomes.
  • To evaluate HPV cfDNA for detecting minimal residual disease and monitoring treatment response.

Main Methods:

  • Detection of HPV cfDNA using quantitative PCR, digital droplet PCR, or next-generation sequencing.
  • Analysis of HPV cfDNA levels at initial presentation and longitudinally during treatment.
  • Correlation of HPV cfDNA levels with clinicopathologic variables and treatment outcomes.

Main Results:

  • Initial HPV cfDNA levels are linked to poor prognostic factors like advanced stage and metastasis.
  • Persistent or rising HPV cfDNA levels indicate treatment relapse.
  • In some cases, HPV cfDNA detection predicted treatment failure before imaging.

Conclusions:

  • HPV cfDNA liquid biopsy shows potential for managing HPV-associated cancers.
  • It may aid in detecting minimal residual disease, assessing treatment response, and monitoring disease progression.
  • This approach offers advantages over traditional diagnostic methods for HPV+ cancers.